Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Increased p53 site-specific DNA binding in cells producing mutant p53

C Dees1, C C Travis

  • 1Health Sciences Research Division, Oak Ridge National Laboratory, TN 37831-6109, USA.

Cancer Letters
|September 25, 1995
PubMed
Summary

Chemotherapy and DNA-damaging agents can activate mutant p53 protein. This may increase cancer cells' transformation and tumor growth potential, highlighting risks associated with these treatments.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer risk management A review of 132 federal regulatory decisions.

Environmental science & technology·2012
Same author

Bioconcentration of organics in beef, milk, and vegetation.

Environmental science & technology·2012
Same author

Determining an acceptable level of risk.

Environmental science & technology·2011
Same author

Drinking-water standards.

Environmental science & technology·2011
Same author

Effectiveness of Purge-and-Trap for Measurement of Volatile Organic Compounds in Aged Soils.

Analytical chemistry·2011
Same author

Treatment of murine cutaneous melanoma with near infrared light.

Photochemistry and photobiology·2002

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The p53 protein is a critical tumor suppressor.
  • Mutations in p53 are common in human cancers.
  • The role of p53 in response to DNA-damaging agents is complex.

Purpose of the Study:

  • To investigate the effect of chemotherapeutic and DNA-damaging agents on p53 DNA binding.
  • To determine if these agents enhance the transformation state of cells with mutant p53.

Main Methods:

  • Utilized human breast and rat liver epithelial WBrasII cells producing mutant p53.
  • Employed transfected Saos-2 cells expressing wild type or transforming mutant p53.
  • Assessed p53 site-specific DNA binding following exposure to agents.

Related Experiment Videos

Main Results:

  • Chemotherapeutic and DNA-damaging agents increased p53 site-specific DNA binding in cells with mutant p53.
  • This effect was also observed in cells with wild type or transforming mutant p53.
  • Exposure enhanced the transformation state and tumorigenic potential of cells with transforming p53 mutants.

Conclusions:

  • Cells with transforming p53 mutants may become more tumorigenic when exposed to chemotherapy or DNA-damaging agents.
  • This suggests a potential mechanism for treatment-induced cancer progression.
  • Further research is needed to understand the clinical implications of these findings.